• Charting The Future Of Antimicrobial Resistance

    A conversation with Ajit Parhi, Ph.D., chief scientific officer, TAXIS Pharmaceuticals Antimicrobial resistance (AMR) poses a grave threat to global public health and is estimated to cause around 10 million deaths each year by 2050if not addressed. While U.S. government prioritization of AMR is likely [...]

  • Clinical Leader: The Rise Of Antimicrobial Resistance And Strategic Research Imperatives For 2026

    By Gregory G. Mario, MBA, president and CEO, TAXIS Pharmaceuticals The ground beneath our feet is shifting. The foundational promise of modern medicine — that bacterial infections are a solvable problem – is being severely tested by an accelerating crisis: antimicrobial resistance (AMR). 2025 brought [...]

  • ContagionLive logo

    Contagion Live: Addressing Resistance to Pathogens Like NDM-CRE Through the Lens of Antimicrobial Development

    US infections caused by NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE) increased by more than 460% from 2019 to 2023, according to a Centers for Disease Control and Prevention (CDC) analysis published in Annals of Internal Medicine. CDC cautions that this surge could raise overall carbapenem-resistant Enterobacterales (CRE) infections [...]

  • The Bio Report Logo

    Podcast Interview: The Bio Report: Overcoming Antibiotic Resistance

    Podcast Interview: The Bio Report: Overcoming Antibiotic Resistance Listen to the podcast here. Antimicrobial resistance is projected to kill up to 10 million people a year by 2050. One particular area of concern is drug-resistant gonorrhea, where existing therapies are being exhausted. Taxis Pharmaceuticals is [...]

  • TAXIS Pharmaceuticals Chief Scientific Officer Ajit Parhi, PhD, discusses dihydrofolate reductase inhibitors on contagion live

    Contagion Live: A Group of Antimicrobial Compounds Shows Novelty Action Against Multidrug-Resistant Gonorrhea

    TAXIS Pharmaceuticals Chief Scientific Officer Ajit Parhi, PhD, discusses dihydrofolate reductase inhibitors as a novel approach to combat resistant Neisseria gonorrhoeae, a rapidly spreading, deadly, and highly resistant strain of Neisseria gonorrhoeae.

  • drug-discovery-online logo

    Tackling Antimicrobial Resistance With Precision Targeting in Drug Discovery Online

    A conversation with Gregory G. Mario and Ajit K. Parhi, Ph.D., TAXIS Pharmaceuticals originally published in Drug Discovery Online.

  • Contagion Fall 2024 cover

    Contagion Live: Funding Isn’t Everything: Bringing Pharma to the Table for the Pasteur Act

    The prospective bill, the Pasteur Act, is one potential strategy to help in these areas, and incentivize pharmaceutical companies to develop these essential therapies. This article was originally published on contagionlive.com.  

  • Genetic Engineering & Biotechnology News

    Genetic Engineering & Biotechnology News: The Antimicrobial Resistance Crisis

    This article was originally published in Genetic Engineering & Biotechnology News under the title of The Antimicrobial Resistance Crisis Eradicating a Global Health Threat

  • Podcast interview, CareTalk: Healthcare. Unfiltered. Reversing the Rapid Rise of Antibiotic Resistance

    Reversing the Rapid Rise of Antibiotic Resistance. Greg Mario joins David E. Williams to discuss the real and potentially imminent dangers of antibiotic-resistant infections and the new technologies being developed to combat this growing threat.